Effects of long-term humidification therapy in bronchiectasis patients and overlap (bronchiectasis/asthma)

A. Annunziata (Naples, Italy), A. Di Giorgio (Naples, Italy), M. Lanza (Naples, Italy), R. Cauteruccio (Naples, Italy), V. Di Spirito (Naples, Italy), I. Meoli (Naples, Italy), F. Stefanelli (Naples, Italy), F. De Simone (Naples, Italy), G. Fiorentino (Naples, Italy)

Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation
Session: Novel interventions and models of pulmonary rehabilitation
Session type: Thematic Poster
Number: 3973
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Annunziata (Naples, Italy), A. Di Giorgio (Naples, Italy), M. Lanza (Naples, Italy), R. Cauteruccio (Naples, Italy), V. Di Spirito (Naples, Italy), I. Meoli (Naples, Italy), F. Stefanelli (Naples, Italy), F. De Simone (Naples, Italy), G. Fiorentino (Naples, Italy). Effects of long-term humidification therapy in bronchiectasis patients and overlap (bronchiectasis/asthma). 3973

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of inhaled bronchodilator therapy on the bacterioexcretion and on the quality of life (LQ) of pulmonary TB patients with concomitant lung obstructive syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006

Treatment effect of inhaled prolonged bronchodilator therapy (IPBT) combined with inhaled glucocorticosteroids (IGCS) on respiratory symptoms and external respiratory function in MDR pulmonary TB patients with broncho-obstructive syndrome (BOS)
Source: Annual Congress 2012 - New insights in the clinical management of lung diseases
Year: 2012

Home based humidification therapy for patients with COPD and bronchiectasis
Source: Annual Congress 2004 - Exercise and systemic effects in COPD
Year: 2004


Effects of pulmonary rehabilitation in patients with indication for noninvasive ventilation therapy (NIPPV)
Source: Eur Respir J 2001; 18: Suppl. 33, 224s
Year: 2001

Effectiveness of pulmonary rehabilitation including occupational therapy (OT) on the prognosis of patients with COPD
Source: Annual Congress 2012 - New adjuncts and modalities in pulmonary rehabilitation
Year: 2012


The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008


Effects of a combination of pulmonary rehabilitation (PR) and non invasive ventilation (NIV) in patients with advanced interstitial lung disease (ILD)
Source: Annual Congress 2009 - Noninvasive ventilation in chronic respiratory failure
Year: 2009


The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 424s
Year: 2001

Liquid long-term oxygen therapy (LTOT) improves health status in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 709s
Year: 2005

Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016


Dose-dependent effects of bronchodilator therapy on the clinical outcomes of exacerbation of COPD requiring non-invasive ventilation (NIV)
Source: Eur Respir J 2003; 22: Suppl. 45, 403s
Year: 2003

Inhaled corticosteroids and survival in patients with COPD receiving long-term home oxygen therapy
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005


Longitudinal performance of the bronchiectasis severity index (BSI) in patients on regular intravenous (IV) antibiotic therapy for bronchiectasis
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016

Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


The influence of type of inhalation device on adherence of COPD patients to inhaled medication
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


Indacaterol/glycopyrronium (IND/GLY) reduces exacerbation and improves lung function versus salmeterol/fluticasone (SFC) in patients with and without prior ICS use: The FLAME study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016

Effects of a pulmonary rehabilitation (PR) in outpatients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 183s
Year: 2002

Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Year: 2020




Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 553s
Year: 2007

Long-term safety of bilateral targeted lung denervation in patients with COPD in a single procedure
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015